We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Ulta Beauty
ULTA
$24.3B
| $63.1K | 0.01% |
134
-5
| -4% | -$2.45K |
|
627
Cencora
COR
$61.2B
| $62.7K | 0.01% |
326
+28
| +9% | +$4.84K |
|
628
Lloyds Banking Group
LYG
$91.3B
| $62.6K | 0.01% |
28,473
-3,588
| -11% | -$8.23K |
|
629
Nutrien
NTR
$30.7B
| $62.3K | 0.01% |
1,055
+43
| +4% | +$2.74K |
|
630
Deckers Outdoor
DECK
$13.3B
| $62.3K | 0.01% |
708
| – | – |
|
631
ENI
E
$77.5B
| $62.2K | 0.01% |
2,160
-14
| -0.6% | -$406 |
|
632
Vulcan Materials
VMC
$36.9B
| $62K | 0.01% |
275
+22
| +9% | +$4.22K |
|
633
Synchrony
SYF
$25.6B
| $62K | 0.01% |
1,827
+157
| +9% | +$4.79K |
|
634
Deutsche Bank
DB
$71.5B
| $61.4K | 0.01% |
5,834
-1,408
| -19% | -$14.8K |
|
635
Haleon
HLN
$44.2B
| $61.3K | 0.01% |
7,317
+340
| +5% | +$2.9K |
|
|
OCCI
636
OFS Credit Co
OCCI
$74.9M
| $60.9K | 0.01% |
7,287
+287
| +4% | +$2.59K |
|
637
West Pharmaceutical
WST
$24.9B
| $60.8K | 0.01% |
159
-22
| -12% | -$7.86K |
|
638
Verisk Analytics
VRSK
$25B
| $60.8K | 0.01% |
269
+68
| +34% | +$14.3K |
|
639
Archrock
AROC
$5.8B
| $60.8K | 0.01% |
5,930
| – | – |
|
640
KraneShares Global Carbon Strategy ETF
KRBN
$133M
| $60.7K | 0.01% |
1,600
+100
| +7% | +$3.88K |
|
641
Telkom Indonesia
TLK
$14.9B
| $60.6K | 0.01% |
2,272
+267
| +13% | +$7.41K |
|
|
AGEN
642
Agenus
AGEN
$290M
| $60.6K | 0.01% |
1,893
+1,798
| +1,893% | +$57.5K |
|
643
Schwab International Equity ETF
SCHF
$68.7B
| $60.1K | 0.01% |
3,374
| – | – |
|
644
Aptiv
APTV
$10.3B
| $60K | 0.01% |
588
-70
| -11% | -$6.92K |
|
645
State Street SPDR S&P Telecom ETF
XTL
$543M
| $59.9K | 0.01% |
+772
| New | +$57.7K |
|
646
Match Group
MTCH
$8.55B
| $59.4K | 0.01% |
1,420
+515
| +57% | +$18.8K |
|
647
Equinor
EQNR
$92.4B
| $59.4K | 0.01% |
2,033
-29
| -1% | -$826 |
|
648
Casella Waste Systems
CWST
$5.69B
| $59.3K | 0.01% |
656
| – | – |
|
|
CYBR
649
DELISTED
CyberArk
CYBR
| $59.1K | 0.01% |
378
-3
| -0.8% | -$430 |
|
650
Jabil
JBL
$35.8B
| $59K | 0.01% |
547
+11
| +2% | +$969 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.